vs
Side-by-side financial comparison of CBRE Group (CBRE) and Merck & Co. (MRK). Click either name above to swap in a different company.
Merck & Co. is the larger business by last-quarter revenue ($16.3B vs $10.5B, roughly 1.5× CBRE Group). CBRE Group runs the higher net margin — 3.0% vs 0.9%, a 2.2% gap on every dollar of revenue. On growth, CBRE Group posted the faster year-over-year revenue change (22.0% vs 4.9%). Over the past eight quarters, CBRE Group's revenue compounded faster (13.0% CAGR vs 0.5%).
CBRE can refer to:Canadian Brotherhood of Railway Employees, a railway trade union in Canada Chemical, Biological, Radiological and Explosive Defence Group, a counter-terrorism unit in Singapore CBRE Group, a multinational real estate corporation Certified broadcast radio engineer, a professional title regulated by The Society of Broadcast Engineers
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fourth on the list of largest biomedical companies by revenue.
CBRE vs MRK — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $10.5B | $16.3B |
| Net Profit | $318.0M | $141.0M |
| Gross Margin | 17.6% | 74.2% |
| Operating Margin | 4.9% | — |
| Net Margin | 3.0% | 0.9% |
| Revenue YoY | 22.0% | 4.9% |
| Net Profit YoY | 95.1% | -9.5% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $10.5B | $16.3B | ||
| Q4 25 | $11.5B | $16.4B | ||
| Q3 25 | $10.1B | $17.3B | ||
| Q2 25 | $9.6B | $15.8B | ||
| Q1 25 | $8.8B | $15.5B | ||
| Q4 24 | $10.2B | $15.6B | ||
| Q3 24 | $8.8B | $16.7B | ||
| Q2 24 | $8.2B | $16.1B |
| Q1 26 | $318.0M | $141.0M | ||
| Q4 25 | $416.0M | $3.0B | ||
| Q3 25 | $363.0M | $5.8B | ||
| Q2 25 | $215.0M | $4.4B | ||
| Q1 25 | $163.0M | $5.1B | ||
| Q4 24 | $487.0M | $3.7B | ||
| Q3 24 | $225.0M | $3.2B | ||
| Q2 24 | $130.0M | $5.5B |
| Q1 26 | 17.6% | 74.2% | ||
| Q4 25 | 17.3% | 66.2% | ||
| Q3 25 | 17.7% | 77.7% | ||
| Q2 25 | 17.1% | 77.5% | ||
| Q1 25 | 17.1% | 78.0% | ||
| Q4 24 | 18.7% | 75.5% | ||
| Q3 24 | 18.1% | 75.5% | ||
| Q2 24 | 17.6% | 76.8% |
| Q1 26 | 4.9% | — | ||
| Q4 25 | 5.4% | 20.9% | ||
| Q3 25 | 4.8% | 39.0% | ||
| Q2 25 | 3.9% | 31.6% | ||
| Q1 25 | 3.1% | 38.0% | ||
| Q4 24 | 5.8% | 26.7% | ||
| Q3 24 | 4.2% | 24.6% | ||
| Q2 24 | 3.0% | 37.3% |
| Q1 26 | 3.0% | 0.9% | ||
| Q4 25 | 3.6% | 18.1% | ||
| Q3 25 | 3.6% | 33.5% | ||
| Q2 25 | 2.2% | 28.0% | ||
| Q1 25 | 1.9% | 32.7% | ||
| Q4 24 | 4.8% | 24.0% | ||
| Q3 24 | 2.5% | 19.0% | ||
| Q2 24 | 1.6% | 33.9% |
| Q1 26 | — | — | ||
| Q4 25 | $1.38 | $1.19 | ||
| Q3 25 | $1.21 | $2.32 | ||
| Q2 25 | $0.72 | $1.76 | ||
| Q1 25 | $0.54 | $2.01 | ||
| Q4 24 | $1.58 | $1.49 | ||
| Q3 24 | $0.73 | $1.24 | ||
| Q2 24 | $0.42 | $2.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7B | — |
| Total DebtLower is stronger | $5.1B | — |
| Stockholders' EquityBook value | $8.9B | — |
| Total Assets | $30.2B | — |
| Debt / EquityLower = less leverage | 0.57× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.9B | $14.6B | ||
| Q3 25 | $1.7B | $18.2B | ||
| Q2 25 | $1.4B | $8.6B | ||
| Q1 25 | $1.4B | $9.2B | ||
| Q4 24 | $1.1B | $13.7B | ||
| Q3 24 | $1.0B | $14.6B | ||
| Q2 24 | $928.0M | $11.4B |
| Q1 26 | $5.1B | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $8.9B | — | ||
| Q4 25 | $8.9B | $52.6B | ||
| Q3 25 | $8.5B | $51.9B | ||
| Q2 25 | $8.3B | $49.0B | ||
| Q1 25 | $8.3B | $48.3B | ||
| Q4 24 | $8.4B | $46.3B | ||
| Q3 24 | $8.7B | $44.5B | ||
| Q2 24 | $8.4B | $43.6B |
| Q1 26 | $30.2B | — | ||
| Q4 25 | $30.9B | $136.9B | ||
| Q3 25 | $28.6B | $129.5B | ||
| Q2 25 | $27.7B | $117.5B | ||
| Q1 25 | $26.4B | $115.1B | ||
| Q4 24 | $24.4B | $117.1B | ||
| Q3 24 | $24.8B | $117.5B | ||
| Q2 24 | $23.5B | $112.6B |
| Q1 26 | 0.57× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-825.0M | — |
| Free Cash FlowOCF − Capex | $-605.0M | — |
| FCF MarginFCF / Revenue | -5.7% | — |
| Capex IntensityCapex / Revenue | 0.8% | — |
| Cash ConversionOCF / Net Profit | -2.59× | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.2B | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $-825.0M | — | ||
| Q4 25 | $1.2B | $2.9B | ||
| Q3 25 | $827.0M | $7.8B | ||
| Q2 25 | $57.0M | $3.3B | ||
| Q1 25 | $-546.0M | $2.5B | ||
| Q4 24 | $1.3B | $3.5B | ||
| Q3 24 | $573.0M | $9.3B | ||
| Q2 24 | $287.0M | $5.6B |
| Q1 26 | $-605.0M | — | ||
| Q4 25 | $1.1B | $1.8B | ||
| Q3 25 | $743.0M | $6.8B | ||
| Q2 25 | $-17.0M | $2.5B | ||
| Q1 25 | $-610.0M | $1.2B | ||
| Q4 24 | $1.2B | $2.5B | ||
| Q3 24 | $494.0M | $8.5B | ||
| Q2 24 | $220.0M | $4.8B |
| Q1 26 | -5.7% | — | ||
| Q4 25 | 9.4% | 11.1% | ||
| Q3 25 | 7.4% | 39.6% | ||
| Q2 25 | -0.2% | 16.0% | ||
| Q1 25 | -7.0% | 7.5% | ||
| Q4 24 | 12.2% | 16.1% | ||
| Q3 24 | 5.6% | 51.1% | ||
| Q2 24 | 2.7% | 30.1% |
| Q1 26 | 0.8% | — | ||
| Q4 25 | 1.3% | 6.3% | ||
| Q3 25 | 0.8% | 5.7% | ||
| Q2 25 | 0.8% | 4.8% | ||
| Q1 25 | 0.7% | 8.6% | ||
| Q4 24 | 0.9% | 6.0% | ||
| Q3 24 | 0.9% | 4.7% | ||
| Q2 24 | 0.8% | 4.9% |
| Q1 26 | -2.59× | — | ||
| Q4 25 | 2.94× | 0.96× | ||
| Q3 25 | 2.28× | 1.35× | ||
| Q2 25 | 0.27× | 0.74× | ||
| Q1 25 | -3.35× | 0.49× | ||
| Q4 24 | 2.75× | 0.92× | ||
| Q3 24 | 2.55× | 2.94× | ||
| Q2 24 | 2.21× | 1.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
